Penalty Amount
$7,400,000,000
The U.S. Bankruptcy Court confirmed a $7.4 billion settlement between Purdue Pharma, the Sackler Family, and 55 attorneys general to resolve claims over the opioid crisis. Connecticut will receive up to $64 million for treatment, prevention, and victim support. The settlement bars the Sacklers from selling opioids and requires public disclosure of documents.
Purdue and the Sacklers must pay $7.4 billion over 15 years, with early payments for opioid treatment and victim support. The Sacklers are permanently barred from the U.S. opioid market and must publicly release over 30 million documents related to their business.
In-house legal teams should review contracts with pharmaceutical entities for clauses addressing fraudulent marketing, settlement payment schedules, and court-ordered injunctions. Verify compliance with document production requirements and allocations to victim support funds. Ensure that contracts include provisions for opioid-related liabilities and multistate litigation risks.
Entity
Purdue Pharma
Industry
Healthcare"Purdue Pharma"
"$7.4 billion"
"peddled a series of falsehoods to push patients toward its opioids"
$7.4B
Connecticut Attorney General William Tong announced that Purdue Pharma will dissolve as the company’s bankruptcy concludes and a $7.4 billion settlement with Purdue and the Sackler family takes effect. The settlement permanently bars the Sacklers from selling opioids in the U.S., directs funds to addiction treatment and prevention, and requires the release of over 30 million documents related to Purdue’s opioid business. Connecticut is expected to receive $64 million from the settlement, with first payments anticipated in fall 2026.
$7.4B
New York Attorney General Letitia James announced the shutdown of opioid manufacturer Purdue Pharma as part of a $7.4 billion settlement with a bipartisan coalition of 54 other state attorneys general. The Sackler family, former owners of Purdue, are permanently barred from selling opioids in the U.S. and have no involvement in Knoa Pharma, the new public benefit corporation replacing Purdue. Purdue was sentenced on criminal charges related to its role in the opioid crisis on April 28, 2026, with the new entity operating under strict oversight and excess revenue funding opioid abatement efforts.
$2.0M
Attorney General Tong and a coalition of four other states and the FTC sued Zillow and Redfin after Zillow paid Redfin $100 million to shut down its multifamily rental advertising business and transfer clients to Zillow. The settlement requires the companies to restore competition, with Redfin rebuilding its apartment advertising business, and pay $2 million to the coalition.
Attorney General William Tong sent a letter to the Connecticut Insurance Department urging rejection of double-digit rate increases sought by Anthem, ConnectiCare, and UnitedHealthcare for individual and small group health insurance plans covering about 220,000 people. The letter argues the rates exceed inflationary measures and criticizes the carriers for failing to control costs and for poor claims system management, particularly ConnectiCare's transition to Molina Healthcare.
$275K
Connecticut Attorney General William Tong announced a $275,000 settlement with TaxAct, an online tax preparation company, over allegations that between January 2018 and December 2022, TaxAct improperly disclosed detailed customer financial information to Meta and Google through third-party tracking technologies without notifying taxpayers. The settlement requires TaxAct to pay $275,000 and implement new third-party tracking compliance measures, including a review committee, written policies, a tag monitoring system, and two independent third-party audits.
$4.0M
Connecticut Attorney General William Tong and the Federal Trade Commission announced a $4 million settlement with Manchester City Nissan (Chase Nissan LLC) resolving allegations that the dealership double-charged for 'certified pre-owned' vehicles and collected unauthorized junk fees. The settlement requires payment for consumer redress, prohibits misrepresentations, mandates clear disclosure of the maximum total price, and requires express informed consent for all charges.